275.31 0.00 (0.00%)
After hours: 5:31PM EDT
|Bid||267.69 x 1000|
|Ask||278.00 x 800|
|Day's Range||274.75 - 285.62|
|52 Week Range||261.35 - 355.88|
|Beta (3Y Monthly)||1.05|
|PE Ratio (TTM)||22.64|
|Earnings Date||Apr 30, 2019 - May 6, 2019|
|Forward Dividend & Yield||2.00 (0.71%)|
|1y Target Est||364.55|
Inovalon (INOV), a leading technology company providing advanced, cloud-based platforms empowering data-driven healthcare, today announced a multi-year engagement with Humana Inc. (HUM), a consumer-focused, technology-driven health plan known for its commitment to innovation, to implement the Inovalon ONE® Platform as part of its data-driven strategy to improve outcomes and economics for members across 17 states. Humana’s engagement will implement a broad set of modules within the Inovalon ONE® Platform ranging from capabilities for data integration, connectivity, and visualization, to advanced analytics and data-driven intervention support, to prospectively identify and predict patient gaps and improve insights into disease diagnosis, progression, documentation, and accuracy across member populations in 17 states.
Accolade and Humana Inc. (HUM) announced today that the two companies will integrate their capabilities to create a differentiated healthcare and benefits experience for consumers. The companies will bring employers and their health plan members the benefit of Humana’s provider networks and innovative medical, dental, pharmacy, Employee Assistance Program (EAP), Work-life Services, and Go365 wellness reward program capabilities together with Accolade’s robust member engagement services and integrated health and benefits partner programs. With a mission to dramatically improve consumer engagement, experience, outcomes and costs in healthcare, Humana with Accolade leverages an open and intelligent platform and a personalized advocacy solution to create a whole person, whole population health offering for its self-funded employer clients, their employees and families.
Humana Inc. agreed pay $500,000 — plus $250,000 in attorney fees and costs — to settle a pregnancy-discrimination lawsuit. The New Jersey Law Journal reports that a former employee sued the Louisville-based health insurance company, claiming that it unlawfully fired her when she became pregnant. U.S. District Judge Freda Wolfson in New Jersey entered judgment Friday in favor of Kate Jenkins, according to the report.
Harvesters–The Community Food Network, Sunflower Medical Group and Humana Inc. (HUM), announce a mobile food collaboration that will offer members of the community fresh, nutritious food items at Sunflower’s location in Kansas City, Kan. on the fourth Saturday of each month, at 1:00 p.m. CT, beginning March 23rd, 2019. Patients of the Health System, as well as members of the Greater Kansas City area that are in need of food, can visit Heartland Primary Care at 2040 Hutton Rd, Kansas City, Kan. where they can receive food, at no cost.
SurgCenter Development, a national ambulatory surgery center system with a network of more than 100 partnered surgery centers in 24 states, and leading health and well-being company Humana Inc.
Humana Inc NYSE:HUMView full report here! Summary * Perception of the company's creditworthiness is neutral * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is extremely low for HUM with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting HUM. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold HUM had net inflows of $2.33 billion over the last one-month. While these are not among the highest inflows of the last year, the rate of inflow is increasing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swap | NeutralThe current level displays a neutral indicator. HUM credit default swap spreads are within the middle of their range for the last three years.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Designed to Benefit Humana Medicare Advantage Members
As previously disclosed, Humana Inc. (HUM) will be hosting an Investor Meeting in New York City on Tuesday, March 19, 2019, at 8:30 a.m. eastern time. The Investor Meeting will include a number of presentations by company leaders focusing on Humana’s strategic direction, operational and financial progress as well as expectations for future performance. Humana encourages the investing public and media to listen to its Investor Meeting via the Internet since attendance at the event is by invitation only.
Let's talk about the popular Humana Inc. (NYSE:HUM). The company's shares received a lot of attention from a substantial price movement on the NYSE over the last few months, increasingRead More...
Managed care stocks are approaching support as investors make sense of a proposed "Medicare-for-All" bill. Let's explore three trading ideas.
The intraday U-turn in the SPDR Health Care Select Sector ETF has produced a "bearish engulfing" reversal chart pattern, which many technicians would say warns that the 2-month uptrend in the sector has ended. The ETF (XLV) opened $93.28, above the Friday's close of $92.95, then rose to a 3-month high of $93.45 in intraday trade before reversing course to close at $91.69, or below Friday's open of $92.22. Candlestick-chart followers believe this pattern suggests that after bears took the bulls' best shot, they launched a successful counterattack that have left bulls retreating. The XLV's decliners Monday were led by shares of managed care companies WellCare Health Plans Inc. , Anthem Inc. and Humana Inc. . Among some downside levels to watch are the 200-day moving average, which currently extends to $89.23, and the 61.8% Fibonacci retracement of the rally off the Dec. 24 closing low to Friday's high, which comes in at $85.38. The XLV has gained 6.0% year to date while the S&P 500 has run up 13.0%.
Shares of managed care and provider companies slumped for a second-straight session Thursday, in the wake of the introduction of the Medicare-for-All Act to Congress on Wednesday. The bill, introduced by Reps. Pramila Jayapal of Washington, Debbie Dingell of Michigan and others looks for a quick 2-year transition out of employer-sponsored coverage into single-payor Medicare run by the government. Analyst Gary Taylor at J.P. Morgan said he doesn't expect a quick snap-back rally in the managed care and provider stocks this week, but doesn't believe they could rally off lows by summer. He then expects that rally to fade into the second half of the year, as Democratic Presidential debates begin in the fall. Shares of UnitedHealth Group Inc. lost 3% to pace the Dow Jones Industrial Average's decliners, after losing 4.9% on Wednesday; Cigna Corp. sank 3.4%, after falling 4.0% on Wednesday; Humana Inc. shed 1.0% after dropping 4.8% the day before; WellCare Health Plans Inc. slid 3.3% after giving up 3.9% Wednesday; and Anthem Inc. declined 1.8% after losing 3.6% on Wednesday. In comparison, the Dow slipped 0.2% after easing 0.3% the day before.
U.S. equities are dribbling lower on Thursday as the Trump-Kim summit in Hanoi abruptly ended with no agreement. Adding to the pressure was a batch of weak economic data overnight out of Asia and a stronger-than-expected Q4 GDP report here at home, which could potentially up the pressure on the Federal Reserve to resume its rate hikes.Moreover, the bulls continue to be content with overhead technical resistance near the 2,800 level on the S&P 500 -- a level that has been in play since October.Breath is breaking down a bit here, as traders tighten up positions after a historic start to the year. Healthcare stocks, in particular, are looking vulnerable as politicians once again talk about moving to a single-payer system in the United States.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 10 Best High-Growth Stocks for Young Investors Here are four healthcare stocks to avoid: Cigna (CI)Source: Shutterstock Shares of Cigna (NYSE:CI), a global health insurance company that was the subject of a proposed $47 billion takeover offer from Anthem in 2015 that was rejected on antitrust grounds, is threatening a share price breakdown with a test of the lows seen in December. Shares are already down more than 20%.The company will next report results on May 3 before the bell. Analysts are looking for earnings of $3.71 per share on revenues of $33 billion. When the company last reported on Feb. 1, earnings of $2.46 missed estimates by 3 cents on a 29.3% rise in revenues. United Health Group (UNH)Source: Shutterstock Health plan provider United Health Group (NYSE:UNH) is watching its shares drop below their 200-day moving average in an accelerating breakdown from a recent two-month consolidation range. That marks a loss of 11% from recent levels and 13% from the highs set back in December. Political pressure is building against the health insurance companies, with Democrats in the House calling for Medicare for all, which would effectively end the private insurance market. * 10 Blue-Chip Stocks to Lead the Market The company will next report results on April 16 before the bell. Analysts are looking for earnings of $3.6 per share on revenues of $59.7 billion. When the company last reported on Jan. 15, earnings of $3.28 beat estimates by 6 cents on a 12.2% rise in revenues. CVS Health (CVS)Source: Mike Mozart via FlickrShares of CVS Health (NYSE:CVS) are cratering, down another 0.6% as I write this to cap a loss of nearly 30% from the double-top high near $80 set back in November. The company recently disappointed investors with some downside guidance as investors await the outcome of the of a court decision on the merger with Aetna in a $69 billion deal.The company will next report results on May 22 before the bell. Analysts are looking for earnings of $1.6 per share on revenues of $59.7 billion. When the company last reported on Feb. 20, earnings of $2.1 beat estimates by 8 cents on a 12.5% rise in revenues. Humana (HUM)Source: Shutterstock Shares of health insurer Humana (NYSE:HUM) have broken down below their lower Bollinger Band and 50-day moving average, accelerating a downtrend that looks set to test the January low for a loss of around 7% from here. Shares have already lost more than 18% from the highs seen back in November. Shares were recently initiated with an overnight rating by analysts at Stephens. Poor timing. * 7 Reasons Kraft Heinz Stock Is a Contrarian Buy The company will next report results on May 8 before the bell. Analysts are looking for earnings of $4.3 per share on revenues of $15.7 billion. When the company last reported on Feb. 6, earnings of $2.6 per share beat estimates by 12 cents on a 7.4% rise in revenues.As of this writing, William Roth did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * The 5 STARS Stocks That Continue to Define the Future * 7 of the Best ETFs to Buy for a Rock-Solid Portfolio * 5 Real Estate Stocks to Buy for Dividend Income Compare Brokers The post 4 Sickly Healthcare Stocks to Avoid appeared first on InvestorPlace.
Humana Inc. announced today that Bruce D. Broussard, President and Chief Executive Officer, will make a presentation to investors at the Barclays Global Healthcare Conference on Tuesday, March 12, 2019, at 10:45 a.m.
Humana members with chronic conditions who utilize specialty medications can rest assured their prescriptions will arrive safely and on-time thanks to a partnership between Humana Pharmacy, the mail-delivery pharmacy service of Humana Inc. (HUM), and ParcelShield, the leader in technology driven critical package protection. According to the Centers for Disease Control and Prevention, chronic disease is a leading driver of health care costs and 6 in 10 Americans live with at least one chronic disease, such as heart disease, cancer, multiple sclerosis, and rheumatoid arthritis. Medication adherence is a big factor in managing these diseases and helping patients stay healthy.
The sales come as Humana's share price is on the rise again after reaching a historic high and a low for the year in the same quarter.
By coordinating care and best practices, the health systems' patients get better care with cost savings all around.